Revenue Update on Phibro Animal Health Corp(NASDAQ:PAHC)

Phibro Animal Health Corp(NASDAQ:PAHC) announced the earnings results for Fiscal Year 2016 and Q4. The results came in during After-hours on Aug 29, 2016. Company reported revenue of $189.20M. Analysts estimated a revenue of $183.62M. Earnings per share were $0.40. Analysts had estimated an EPS of $0.38.

Phibro Animal Health Corp (PAHC) made into the market gainers list on Thursdays trading session with the shares advancing 5.44% or 1.32 points. Due to strong positive momentum, the stock ended at $25.59, which is also near the day’s high of $25.65. The stock began the session at $24.24 and the volume stood at 3,03,284 shares. The 52-week high of the shares is $37.27 and the 52 week low is $16.8. The company has a current market capitalization of $1,008 M and it has 3,94,07,568 shares in outstanding.

Several Insider Transactions has been reported to the SEC. On May 23, 2016, E Thomas Corcoran (director) purchased 5,000 shares at $18.14 per share price.Also, On Feb 23, 2016, Gerald K Carlson (Chief Operating Officer) sold 8,000 shares at $28.09 per share price.On Feb 19, 2016, Jack Bendheim (President and CEO) sold 2,175 shares at $30.01 per share price, according to the Form-4 filing with the securities and exchange commission.

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing manufacturing and marketing products for a range of food animals including poultry swine beef and dairy cattle and aquaculture. The Company operates through three segments: Animal Health Mineral Nutrition and Performance Products. Its Animal Health segment develops manufactures and markets more than 550 product presentations including antibacterials nutritional specialty products and vaccines. Mineral Nutrition segment manufactures and markets more than 425 formulations and concentrations of trace minerals such as zinc manganese copper iron and other compounds with a focus on customers in North America. The Company’s Performance Products segment manufactures and markets specialty ingredients for use in the personal care automotive industrial chemical and chemical catalyst industries predominantly in the United States.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Phibro Animal Health Corp - Is it time to Sell?

Top Brokerage Firms are advising their investors on Phibro Animal Health Corp. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.